News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

UnitedHealthcare Introduces ‘myEasyBook’ Online Shopping Service to Help Consumers Select Hospitals, Physicians, and Clinical Pathology Laboratories

Targeted at employers and their employees, myEasyBook is designed to help consumers with high-deductible health plans save 30% or more when picking a provider

It is rare for a national health insurance company to use the 2014 International Consumer Electronics Show in Las Vegas to unveil a new online healthcare service, but that’s exactly what UnitedHealthcare Group (NYSE: UNH) did. On January 7, it took the wraps off its new myEasyBook healthcare shopping service.

Clinical laboratory managers and pathologists should take note of this development. It is one more example of how prominent healthcare companies want to help consumers shop for healthcare providers by providing information about quality and price in an easy-to-use format. Every medical laboratory should be thinking about when and how it wants to make its quality information and lab test pricing readily available to consumers. (more…)

Kaiser Identifies and Ranks 10 Highest-Price Markets for Health Insurance and Determines that Lack of Competition Is One Contributing Factor

Pathologists may be surprised to learn that the nation’s highest-cost markets for health insurance include Colorado ski resorts and rural regions

What do the 10 most expensive U.S. health insurance markets have in common? According to a story published by Kaiser Health News, the 10 highest-priced markets are characterized by lack of competition among doctors, hospitals and insurers.

That will probably not be a surprise to most clinical laboratory managers and pathologists, particularly if they work for a health system that has lots of market clout in their community. That’s because concentration of market share by just a few powerful hospitals or health systems is associated with higher prices for healthcare. However, there are exceptions. (more…)

National Institutes of Health Creates Partnership with Big Pharma to Improve Development Success of New Drugs and Diagnostics and Speed FDA Clearance

Pathology groups and clinical laboratories are among the beneficiaries if the Accelerating Medicines Partnership achieves its goals

Power players in healthcare are about to invest nearly a quarter of a billion dollars to accelerate the time it takes for new medical discoveries to gain regulatory approval and enter clinical use. The emphasis will be on both therapeutic drugs and diagnostics, making this an important development for in vitro diagnostics companies and medical laboratories.

Anchors to this new initiative are the National Institutes of Health (NIH) and the Food and Drug Administration (FDA). Their partners are 10 pharmaceutical companies and six nonprofit groups. The goal is to jumpstart research to find targets for new drugs and diagnostics, noted a Genomeweb.com article. (more…)

Kaiser’s Ranking of 10 Least Expensive Markets for Health Insurance Contain Surprises and Show Where Prices for Pathology and Clinical Laboratory Testing May be Cheapest

Study by Kaiser Health News and NPR shows that Minnesota, Northwestern Pennsylvania, and Tucson, Arizona are among the least expensive health insurance markets in the United States

Are you lucky to live in one of the nation’s 10 lowest-cost markets for health insurance? Researchers at the Kaiser Family Foundation published a study that identifies the 10 regional markets in the United States where health insurance costs are the cheapest.

Pathology groups and medical laboratories serving these 10 regions are thus probably getting paid less fee-for-service reimbursement than in other more expensive regions of the United States. The study shows how variable the cost of the same healthcare insurance plan can be from one city to the next across the nation. (more…)

Study at Boston’s Beth Israel Deaconess Medical Center Determines that 30% of All Clinical Laboratory Tests Are Overused or Medically Unnecessary

BIDMC researchers show that, on average, 30% of all lab tests may be unnecessary and that an equal percentage of tests should not be ordered at all

Every pathologist and clinical laboratory professional knows how often physicians order a medical laboratory test that is inappropriate or unnecessary. That is a problem because, each time a clinician orders an inappropriate test, patient harm is possible. Yet this issue gets little attention from the medical profession at large.

Thus, it is significant that researchers at Beth Israel Deaconess Medical Center (BIDMC), published a study last fall showing that 30% of all medical laboratory tests throughout medicine are overused! A different 30% of medical laboratory tests are underused, as well. (more…)

New Research Findings Determine that ‘Dark Matter’ DNA Does Useful Work and Opens Door to Develop More Sophisticated Clinical Pathology Laboratory Tests

Researchers at Penn State identified 160,000 ‘transcription initiation machines’ throughout the human genome

DNA “dark matter” may have something in common with comedian Rodney Dangerfield, who liked to say, “I don’t get no respect!” As many pathologists know, for years the human exome that has been the focus of most research. This is the 1% of the human genome that contains the genes that produce proteins and do other useful functions.

Meanwhile, the remaining 99% of the human genome—sometimes called “junk DNA” and generally known as dark matter—got relatively little attention from researchers. But that is changing. At Pennsylvania State University, a research team has discovered that coding and noncoding RNA, or genomic dark matter, originates at the same types of locations along the human genome.
(more…)

;